Report Description

Global Xenotransplantation Market is expected to grow at a CAGR of 8.52% and reach USD 1289.11 million in 2031. This can be attributed to the rise in surgeries and improved understanding of immune system. Chronic kidney disease is a major public health issue in the United States, affecting over eight million people. When kidney function reaches a certain point, patients have end-stage renal disease and require dialysis or transplantation to live. More than 340,000 people are currently on dialysis, with 106,000 new patients added in 2019. Over 140,000 people had a functioning kidney transplant in the last 20 years, the prevalence of end-stage renal disease in these two populations has tripled. In 2020, medicare expenditures for end-stage renal disease are expected to exceed USD 28 billion.

Rise in Surgeries Increases the Demand for Xenotransplantation

Some of the factors that are likely to drive the growth of the xenotransplantation market include an increase in the volume of organ transplantation surgeries, an increase in the occurrence of chronic diseases, an increase in investment for the development of advanced and technical products, and an increase in the geriatric population. Changing lifestyles among the growing population, on the other hand, would increase numerous opportunities, which is expected to lead to a growth of xenotransplantation market throughout the forecast period.

Deceased donor kidney transplant was performed on 10,659 patients, while a live donor kidney transplant was performed on 6,432 patients. However, there are currently over 74,000 people on the national waiting list for a deceased donor kidney transplant. Even though the number of kidney transplants performed each year is increasing, the waiting list continues to grow. Every day, twelve people die while waiting for a kidney transplant.

Increasing demand for tissue and organ transplantation fuel the demand for Xenotransplantation

The global demand for organ transplantation has increased rapidly over the last decade due to an increase in the incidence of vital organ failure, rising success, and greater improvement in post-transplant outcome. However, the lack of sufficient organs for transplantation to meet current demand has resulted in major organ shortage crises. As a result, the number of patients on transplant waiting lists and the number of patients dying while on the waiting list has increased significantly.

Improved understanding of immune system to drive Global Xenotransplantation Market

Organ transplantation is one of the success stories of the second half of the twentieth century. Indeed, its success has resulted in the referral of an increasing number of patients, resulting in a scarcity of donor organs. Our better understanding of the immune system and the immune rejection process has resulted in the development of therapies that, in theory, will overcome the robust immune responses associated with xenogeneic tissue transplantation. In the coming years, human clinical trials using animal cells and organs to treat some of these diseases are expected to become a reality.

The introduction of advanced tissue products such as DeNovo NT also boost the Xenotransplantation Market

DeNovo NT Graft is a juvenile cartilage implant that is particulate and used to repair articular cartilage damage. Its purpose is to give surgeons an early-intervention option for articular cartilage repair. The DeNovo NT Graft is a single-stage procedure for treating articular cartilage defects in a variety of anatomical applications such as the knee, ankle, hip, shoulder, and elbow. DeNove having high technological advancement to treat the cases for transplantation.. Since, tissue transpIantation has been made very easy with the help of this technology and also provide relief to the adult patients suffering from cartilage or muscular problems, as a result, boosting the xenotransplantation market worldwide.


Download Free Sample Report

Market Segmentation

The global xenotransplantation market is segmented based on animal type, xeno product, organs, end users, region, and company. Based on animal type, the global xenotransplantation market can be split into pig, baboon, rabbit, and others. Based on xeno product, it can be further categorized into organs, tissues, and cells. Based on organs, the global xenotransplantation, market can be segmented into kidney, liver, heart, cornea, and others. Based on end-user, the market is segmented into transplant center, hospitals, and others. Regionally, the global xenotransplantation market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the overall global xenotransplantation market with United States having the biggest market. The United States xenotransplantation market is expected to grow at a CAGR of 8.97% and reach 427.39 million in 2031.

Company Profiles

Major companies in the market are Novartis AG, Accord Healthcare, Pfizer, Inc, F. Hoffmann-La Roche Ltd., Terumo Medical Corporation, Transonic, Astellas Pharma, Inc., Preservation Solutions, Inc. Bio Med Pvt. Ltd., and TransMedic, Pte. Ltd. Major players operating in the market are following strategies such as mergers and acquisitions, new therapy, among others, in order to stay competitive and have an edge over other players in the market.

Attribute

Details

Market Size Value in 2021

USD 740.24 million

Revenue Forecast in 2031

USD 1289.11 million

United States Market Size Value in 2025

USD 270.42 million

Growth Rate

8.52%

Base Year

2021

Estimated Year

2022

Forecast Period

2023 – 2031

Quantitative Units

Revenue in USD Million and CAGR for 2021-2031

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Animal Type

·         Xeno Product

·         Organs

·         End User

Regional Scope

North America, Europe, Asia Pacific, South America, Middle East & Africa

Country Scope

United States, Canada, Mexico, Germany, France, Spain, Switzerland, Italy, China, Japan, South Korea, Australia, India, Brazil, Argentina, Colombia, Egypt, Saudi Arabia South Africa, UAE.

Key Companies Profiled

Novartis AG, Accord Healthcare, Pfizer, Inc, F. Hoffmann-La Roche Ltd., Terumo Medical Corporation, Transonic, Astellas Pharma, Inc., Preservation Solutions, Inc. Bio Med Pvt. Ltd., and TransMedic, Pte. Ltd.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 
Report Scope:

In this report, global xenotransplantation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Global Xenotransplantation Market, By Animal Type:

    • Pig
    • Baboon
    • Rabbit
    • Others

·         Global Xenotransplantation Market, By Xeno Product:

    • Organs
    • Tissues
    • Cells

·         Global Xenotransplantation Market, By Organs:

    • Kidney
    • Liver
    • Heart
    • Cornea
    • Others
  • Global Xenotransplantation Market, By End User:
    • Hospitals
    • Transplant Centers
    • Others
  • Global Xenotransplantation Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Spain
      • Switzerland
      • Italy
    • Asia-Pacific
      • China
      • Japan
      • South Korea
      • Australia
      • India
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Egypt
      • Saudi Arabia
      • South Africa
      • UAE 

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Xenotransplantation market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Xenotransplantation Market

5.    Voice of Customer

5.1.  Xenotransplantation Awareness

5.2.  Factors Contributing Switch to Xenotransplantation

5.3.  Preference, By Animal Type

5.4.  Barriers to Adoption of Xenotransplantation

6.    Clinical Trial Analysis

7.    Patent Analysis

8.    Successful Xenotransplantation Case Studies

9.    Global Xenotransplantation Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Animal Type (Pig, Rabbit, Baboon, Others)

9.2.2.     By Xeno Product (Organs, Tissues, Cells)

9.2.2.1.         By Organs (Kidney, Liver, Heart, Cornea, Others)

9.2.3.     By End User (Hospitals, Transplant Centers, Others)

9.2.4.     By Region

9.3.  Product Market Map

10.  North America Xenotransplantation Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

10.2.2.  By Xeno Product (Organs, Tissues, Cells)

10.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

10.2.3.  By End User (Hospitals, Transplant Centers, Others)

10.2.4.  By Country

10.3.              Policy & Regulatory Landscape

10.4.              North America: Country Analysis

10.4.1.  United States Xenotransplantation Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Animal Type

10.4.1.2.2.           By Xeno Product

10.4.1.2.3.           By End User

10.4.2.  Mexico Xenotransplantation Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Animal Type

10.4.2.2.2.           By Xeno Product

10.4.2.2.3.           By End User

10.4.3.  Canada Xenotransplantation Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Animal Type

10.4.3.2.2.           By Xeno Product

10.4.3.2.3.           By End User

11.  Europe Xenotransplantation Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

11.2.2.  By Xeno Product (Organs, Tissues, Cells)

11.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

11.2.3.  By End User (Hospitals, Transplant Centers, Others)

11.2.4.  By Country

11.3.              Policy & Regulatory Landscape

11.4.              Europe: Country Analysis

11.4.1.  Germany Xenotransplantation Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Animal Type

11.4.1.2.2.           By Xeno Product

11.4.1.2.3.           By End User

11.4.2.  France Xenotransplantation Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Animal Type

11.4.2.2.2.           By Xeno Product

11.4.2.2.3.           By End User

11.4.3.  Spain Xenotransplantation Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Animal Type

11.4.3.2.2.           By Xeno Product

11.4.3.2.3.           By End User

11.4.4.  Switzerland Xenotransplantation Market Outlook

11.4.4.1.      Market Size & Forecast

11.4.4.1.1.           By Value

11.4.4.2.      Market Share & Forecast

11.4.4.2.1.           By Animal Type

11.4.4.2.2.           By Xeno Product

11.4.4.2.3.           By End User

11.4.5.  Italy Xenotransplantation Market Outlook

11.4.5.1.      Market Size & Forecast

11.4.5.1.1.           By Value

11.4.5.2.      Market Share & Forecast

11.4.5.2.1.           By Animal Type

11.4.5.2.2.           By Xeno Product

11.4.5.2.3.           By End User

12.  Asia-Pacific Xenotransplantation Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

12.2.2.  By Xeno Product (Organs, Tissues, Cells)

12.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

12.2.3.  By End User (Hospitals, Transplant Centers, Others)

12.2.4.  By Country

12.3.              Policy & Regulatory Landscape

12.4.              Asia-Pacific: Country Analysis

12.4.1.  China Xenotransplantation Market Outlook

12.4.1.1.      Market Size & Forecast

12.4.1.1.1.           By Value

12.4.1.2.      Market Share & Forecast

12.4.1.2.1.           By Animal Type

12.4.1.2.2.           By Xeno Product

12.4.1.2.3.           By End User

12.4.2.  India Xenotransplantation Market Outlook

12.4.2.1.      Market Size & Forecast

12.4.2.1.1.           By Value

12.4.2.2.      Market Share & Forecast

12.4.2.2.1.           By Animal Type

12.4.2.2.2.           By Xeno Product

12.4.2.2.3.           By End User

12.4.3.  South Korea Xenotransplantation Market Outlook

12.4.3.1.      Market Size & Forecast

12.4.3.1.1.           By Value

12.4.3.2.      Market Share & Forecast

12.4.3.2.1.           By Animal Type

12.4.3.2.2.           By Xeno Product

12.4.3.2.3.           By End User

12.4.4.  Japan Xenotransplantation Market Outlook

12.4.4.1.      Market Size & Forecast

12.4.4.1.1.           By Value

12.4.4.2.      Market Share & Forecast

12.4.4.2.1.           By Animal Type

12.4.4.2.2.           By Xeno Product

12.4.4.2.3.           By End User

12.4.5.  Australia Xenotransplantation Market Outlook

12.4.5.1.      Market Size & Forecast

12.4.5.1.1.           By Value

12.4.5.2.      Market Share & Forecast

12.4.5.2.1.           By Animal Type

12.4.5.2.2.           By Xeno Product

12.4.5.2.3.           By End User

13.  South America Xenotransplantation Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Animal Type (Pig, Rabbit, Baboon, Others)

13.2.2.  By Xeno Product (Organs, Tissues, Cells)

13.2.2.1.      By Organs (Kidney, Liver, Heart, Cornea, Others)

13.2.3.  By End User (Hospitals, Transplant Centers, Others)

13.2.4.  By Country

13.3.              Policy & Regulatory Landscape

13.4.              South America: Country Analysis

13.4.1.  Brazil Xenotransplantation Market Outlook

13.4.1.1.      Market Size & Forecast

13.4.1.1.1.           By Value

13.4.1.2.      Market Share & Forecast

13.4.1.2.1.           By Animal Type

13.4.1.2.2.           By Xeno Product

13.4.1.2.3.           By End User

13.4.2.  Argentina Xenotransplantation Market Outlook

13.4.2.1.      Market Size & Forecast

13.4.2.1.1.           By Value

13.4.2.2.      Market Share & Forecast

13.4.2.2.1.           By Animal Type

13.4.2.2.2.           By Xeno Product

13.4.2.2.3.           By End User